© Florida Institue for Clinical Research | Privacy Policy
Website by 
Type 2 Diabetes (NNC0487-0111)
Novo Nordisk NN9490-7678A
The investigation aims to compare how well different doses of the medicine NNC0487-0111 lowers blood sugar in people with Type II diabetes.
To participate in this study you must:
- Be at least 18-75 years of age
- Be diagnosed with type II diabetes mellitus
- Be on a stable dose of metformin with or without SGLT2 inhibitor